MG53: A potential therapeutic target for kidney disease
Abstract Ensuring cell survival and tissue regeneration by maintaining cellular integrity is important to the pathophysiology of many human diseases, including kidney disease. Mitsugumin 53 (MG53) is a member of the tripartite motif‐containing (TRIM) protein family that plays an essential role in re...
Saved in:
Main Authors: | Ben Ke (Author), Wen Shen (Author), Jianling Song (Author), Xiangdong Fang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Growth Factors: Potential Biomarkers and Therapeutic Targets in Kidney Diseases
by: Wei Tang, et al.
Published: (2022) -
MG53 Preserves Neuromuscular Junction Integrity and Alleviates ALS Disease Progression
by: Jianxun Yi, et al.
Published: (2021) -
TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
by: Ye Zixin, et al.
Published: (2022) -
Inhibition of HDAC6 activity in kidney diseases: a new perspective
by: Ben Ke, et al.
Published: (2018) -
Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools
by: Sebastian N. Knoppert, et al.
Published: (2019)